Citalopram use in pregnancy:  A prospective comparative evaluation of pregnancy and fetal outcome.
Published: 2006
Language: eng
Number of pages: 122
ISBN-13: 9780494163863
Description: The effect of citalopram, a selective serotonin reuptake inhibitor, on pregnancy outcome was investigated.Women who took citalopram during pregnancy were matched to a disease-group and to a non-teratogen group of women. Matching criteria included maternal (+/-2 yrs) and gestational (+/-2 wks) age. A telephone follow-up was conducted following delivery.There were 132 women in each group. One hundred and fourteen (86%) women on citalopram had live births, 14 (11%) had spontaneous abortions, 2 (1.5%) had elective terminations and 2 (1.5%) experienced still births. Fetal survival rates, mean birth weights, duration of pregnancies, and major malformations were not statistically different between the groups. There was a relative risk (RR) of 4.2 (CI 95%: 1.6-11.1) in neonates exposed to citalopram close to term to be admitted to the special-care nurseries as compared to the unexposed infants.Late pregnancy use of citalopram was associated with increased risk of poor neonatal adaptation syndrome.
Notes: Source: Masters Abstracts International, Volume: 44-06, page: 2777.

Thesis (M.Sc.)--University of Toronto, 2006.

Electronic version licensed for access by U. of T. users.

ROBARTS MICROTEXT copy on microfiche.